High Tide: From Canadian Cannabis Market Leader to European Powerhouse
Reading Time: 3 minutes
The cannabis product retailer gained increasing recognition in the country in mid-August 2025 when the company entered the German medical cannabis market. High Tide announced the acquisition of 51% of the shares in the Berlin pharmaceutical dealer Remexian and also secured the option to acquire the remaining shares later. Remexian is one of the leading importers and wholesalers in Germany and sold approximately 7 tons of cannabis flowers in the second quarter of 2025, accounting for around 16% of the total amount imported into Germany. On an annual...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
